A Call For Action: Pharma Strategies For Development Of Payor Evidence Programs.
- Resource Type
- Article
- Authors
- Cassese, Marie; Touchot, Nicolas
- Source
- IN VIVO. Feb2012, Vol. 30 Issue 2, p56-63. 8p.
- Subject
- *CORPORATE finance
*RESEARCH funding
DRUG approval
CLINICAL drug trials
DRUG efficacy
- Language
- ISSN
- 2160-9861
The article reveals pharmaceutical plans that enable creation of payor evidence programs. An Easton Associates study showed that corporate spending in post-approval and extension research generated less data that discuss about the progress of a therapy in an actual clinical practice. The study proposed that medical affairs must be applied when creating payor evidence programs, which involves parts of the process including detecting payor uncertainty risks and primary clinical metrics.